Weill Cornell Audiology

Closed
1305 York Ave
New York, NY 10021

Weill Cornell Audiology specializes in providing comprehensive auditory care and services to patients in New York, NY. The institution is dedicated to delivering expert audiological evaluations, diagnoses, and personalized treatment plans.

With a focus on advancing auditory health, Weill Cornell Audiology employs state-of-the-art technology and a team of experienced professionals. Their commitment to patient-centered care ensures that individuals receive tailored solutions for their hearing needs.

Generated from the website

Own this business?
See a problem?

You might also like

Timothy Vartanian, M.D., Ph.D.
Internal medicine practitioners

Timothy Vartanian, M.D., Ph.D.

Timothy Vartanian, MD, PhD, a leading authority on neural regeneration has been named as the Director of the Judith Jaffe Multiple Sclerosis Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He is also appointed to the faculty of the Department of Neurology and Neuroscience at Weill Cornell Medical College. Dr. Vartanian received his medical degree from the Pritzker School of Medicine at the University of Chicago, and his Ph.D. in Biochemistry and Molecular Biology from the University of Chicago. His internship, residency, and two research fellowships were at the prestigious Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Hospital, and Harvard Medical School. Previously, he was chief of the Division of Demyelinating Diseases at Beth Israel Deaconess Medical Center and a member of the faculty of Harvard Medical School.Dr. Vartanian has led research teams that have made groundbreaking discoveries in central nervous system remyelination, novel mechanisms of axonal degeneration and regeneration, and mechanisms of immune mediated injury to myelin and axons in multiple sclerosis. His research interests center on regeneration of the myelin internode in multiple sclerosis, preventing axonal and neuronal injury, and defining the complicated interactions between the immune and nervous systems.His work has been published in top peer reviewed journals including the Journal of Cell Biology, the Proceedings of the National Academy of Science, the Journal of Neuroscience, Science, Nature, and the New England Journal of Medicine.His research is funded by the National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke and the National Multiple Sclerosis Society. He has served on grant review committees for the NIH, National Multiple Sclerosis Society, Congressionally Directed Medical Research through the Department of Defense, The Wellcome Trust, and others.Dr. Vartanian is committed to providing state-of-the-art patient care and advanced treatments in a personalized environment.
Norman Latov, M.D., Ph.D.
Internal medicine practitioners, Psychiatrists and psychoanalysts

Norman Latov, M.D., Ph.D.

Norman Latov, MD, PhD is Professor of Neurology and Neuroscience, and Director of the Peripheral Neuropathy Clinical and Research Center at Weill Cornell Medical College.Dr. Latov graduated from Columbia College in 1970, received the MD, PhD degree from the University of Pennsylvania School of Medicine in 1975, served as Medical Intern at Boston City Hospital, and completed his residency in Neurology at the Neurological Institute of the Columbia Presbyterian Medical Center in 1979, where he also served as Chief Resident. Following a research fellowship in Immunology, he joined the faculty of Columbia University where in 1994 he was appointed Professor of Neurology.Dr. Latov joined the department of Neurology and Neuroscience of the Weill Cornell Medical College in 2001, where he heads the Peripheral Neuropathy Clinical and Research Center. His clinical and laboratory research interests are in Peripheral Neuropathy and Neuroimmunology, focusing on the diagnosis and and treatment of inflammatory neuropathies. His laboratory is credited with the discovery of anti-MAG and GM1 ganglioside antibodies that are implicated in the pathogenesis of autoimmune neuropathies, and for developing blood tests that are currently used to diagnose these conditions. His current research focuses on the use of monoclonal anti-CD204 macrophage receptor antibodies for treatment of neuroimmune and inflammatory diseases. He lectures widely, and has over 200 publications, including research articles, reviews, editorials, chapters and books.Dr. Latov was a founding Board member, Medical and Research Director, and member of the National Advisory Council of the Neuropathy Association, which subsequently merged with the Foundation for Neuropathy. His book "Peripheral Neuropathy: When the Numbness, Weakness and Pain Won't Stop" (American Academy of Neurology) was written with the aim of demystifying the illness for patients and their families and friends. Dr. Latov has been selected as one of America's or New York Metro Area's Top Doctors, by Castle Connolly, annually since 1998.
Norman Latov, M.D., Ph.D.

Norman Latov, M.D., Ph.D.

Norman Latov, MD, PhD is Professor of Neurology and Neuroscience, and Director of the Peripheral Neuropathy Clinical and Research Center at Weill Cornell Medical College.Dr. Latov graduated from Columbia College in 1970, received the MD, PhD degree from the University of Pennsylvania School of Medicine in 1975, served as Medical Intern at Boston City Hospital, and completed his residency in Neurology at the Neurological Institute of the Columbia Presbyterian Medical Center in 1979, where he also served as Chief Resident. Following a research fellowship in Immunology, he joined the faculty of Columbia University where in 1994 he was appointed Professor of Neurology.Dr. Latov joined the department of Neurology and Neuroscience of the Weill Cornell Medical College in 2001, where he heads the Peripheral Neuropathy Clinical and Research Center. His clinical and laboratory research interests are in Peripheral Neuropathy and Neuroimmunology, focusing on the diagnosis and and treatment of inflammatory neuropathies. His laboratory is credited with the discovery of anti-MAG and GM1 ganglioside antibodies that are implicated in the pathogenesis of autoimmune neuropathies, and for developing blood tests that are currently used to diagnose these conditions. His current research focuses on the use of monoclonal anti-CD204 macrophage receptor antibodies for treatment of neuroimmune and inflammatory diseases. He lectures widely, and has over 200 publications, including research articles, reviews, editorials, chapters and books.Dr. Latov was a founding Board member, Medical and Research Director, and member of the National Advisory Council of the Neuropathy Association, which subsequently merged with the Foundation for Neuropathy. His book "Peripheral Neuropathy: When the Numbness, Weakness and Pain Won't Stop" (American Academy of Neurology) was written with the aim of demystifying the illness for patients and their families and friends. Dr. Latov has been selected as one of America's or New York Metro Area's Top Doctors, by Castle Connolly, annually since 1998.
United StatesNew YorkNew YorkWeill Cornell Audiology

Partial Data by Foursquare.